evidencegaps
Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

1,187 questions · 1,248 findings · 108 reviews · Stroke

Sort:Best matchNewestHighest certaintyDownload CSV
No studies found 275 · 22%GRADE not reported 56 · 4.5%Very low 269 · 21.6%Low 349 · 28%Moderate 216 · 17.3%High 83 · 6.7%

Iron chelator vs placebo

SAEs · adults with acute stroke

Iron chelator showed no clear difference in serious adverse events (SAE) compared with placebo (low certainty).

1 finding from 1 review

Iron chelator vs placebo

Death during study period · adults with acute stroke

The review found no eligible studies for this question.

1 finding from 1 review

tDCS vs active control

Secondary outcome measure: lower extremity function at the end of · people with stroke
2 findings from 1 review

tDCS vs active control

Muscle strength · people with stroke
2 findings from 1 review

tDCS vs active control

Secondary outcome measure: cognitive abilities at the end of · people with stroke

The review found no eligible studies for this question.

2 findings from 1 review

tDCS vs active control

Dropouts, adverse events and deaths during intervention phase Numbers of dropouts, adverse events and deaths from all causes · people with stroke

tDCS showed no clear difference in secondary outcome measure: dropouts, adverse events and deaths… compared with any type of active control intervention (moderate certainty).

1 finding from 1 review

tDCS vs placebo or control

Secondary outcome measure: mean upper extremity function at the end of the intervention periodClinical measures of upper extremity function. Scale from: 0 to infinity. · patients with improving activities of daily living, and physical and cognitive functioning at the end of follow‐up, in people after stroke
1 finding from 1 review

tDCS vs placebo or control

Secondary outcome measure: lower extremity function at the end of · patients with improving activities of daily living, and physical and cognitive functioning at the end of follow‐up, in people after stroke

The review found no eligible studies for this question.

1 finding from 1 review

tDCS vs placebo or control

Secondary outcome measure: cognitive abilities at the end of · patients with improving activities of daily living, and physical and cognitive functioning at the end of follow‐up, in people after stroke

The review found no eligible studies for this question.

1 finding from 1 review

tDCS vs placebo or control

Secondary outcome measure: hemispatial neglect at the end of · patients with improving activities of daily living, and physical and cognitive functioning at the end of follow‐up, in people after stroke

The review found no eligible studies for this question.

1 finding from 1 review